Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: drug prices

Internal Due Diligence Review Important for Physician Practices

Steven M. Harris, Esq.  |  June 15, 2015

Whether you’re considering selling your practice, growing your practice or maintaining the status quo, it’s important to periodically do a checkup on your internal operations and compliance with the law. It’s always preferable to discover problems within your practice and correct them (if possible) before those issues are discovered by third parties, such as the…

Filed under:Legal UpdatesPractice SupportProfessional Topics

Can DIY Medicine Tame Rampaging Healthcare Costs?

Simon M. Helfgott, MD  |  April 1, 2015

High health insurance deductibles, physician charges, medication expenses spur patients to seek less costly lab testing, surgical procedures, prescription drugs

Filed under:OpinionPractice SupportRheuminationsSpeak Out Rheum Tagged with:costsHealth InsuranceHelfgottMedicationprescription drugrheumatologysurgical procedure

Generic Colchicine Approved for Gout Prophylaxis

Richard Quinn  |  March 1, 2015

The cost for therapeautic gout treatment may soon go down, thanks to a recent court ruling

Filed under:ConditionsDrug UpdatesGout and Crystalline ArthritisLegislation & AdvocacyResearch Rheum Tagged with:ColchicineGoutQuinnResearchrheumatologyTreatment

What the Affordable Care Act Means for Rheumatology

Bryn Nelson, PhD  |  January 1, 2014

Expected to flood the healthcare system with an influx of insured patients, Obamacare will likely exacerbate physician shortages, worsen capacity issues for many rheumatologists, and pressure providers to deliver a measurable quality of care, but analysts say rheumatology patients will benefit from expanded insurance coverage options

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:ACAACOAffordable Care Act (ACA)druginsurance coverageLegislationMedicareObamacarepatient carephysician shortagerheumatologistrheumatology

The American College of Rheumatology Helps Keep Three Biologics Off the SAD List

Richard Quinn  |  November 19, 2013

In October, the Centers for Medicare and Medicaid Services directed carriers to again include three biologics in Medicare Part B coverage.  (posted Nov. 19)

Filed under:Practice Support Tagged with:BiologicsMedicareMedicare Part B

President’s Perspective: ACR Calls on Members to Advance Rheumatology

Audrey B. Uknis, MD  |  April 1, 2013

Members’ support and participation is needed to strengthen the ACR’s lobbying efforts with Congress

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:AC&RAdvocacyCongressrheumatology

Rheuminations: New Rules for Rheumatologists

Simon M. Helfgott, MD  |  April 1, 2013

Transparent hospital costs, salary caps for senior hospital executives, and no more faxes top one rheumatologist’s wish list for revised healthcare rules

Filed under:OpinionPractice SupportRheuminationsSpeak Out Rheum Tagged with:costsPractice Managementsalaries

No Easy Solution for Lack of Transparency in the Practice of Medicine

Simon M. Helfgott, MD  |  December 1, 2012

Several well-publicized episodes highlight the apparent lack of disclosure of conflicts of interest in medicine, but will disclosure laws fix the problem or add to the confusion?

Filed under:EthicsLegal UpdatesLegislation & AdvocacyOpinionPractice SupportProfessional TopicsQuality Assurance/ImprovementRheuminationsSpeak Out Rheum Tagged with:boneConflict of interestdrugEthicsHelfgottLegalLegislationPractice Managementrheumatologisttransparency

South Korea Okays First Officially Approved Monoclonal Antibody for RA

Kurt Ullman  |  October 17, 2012

11 Products Looking for U.S. Marketing Nod

Filed under:Uncategorized Tagged with:Biosimilarsgeneric drugs

Rheumatology’s Virtual “Water Cooler”

Debra Gordon, MS  |  May 16, 2011

The ACR list serves allow rheumatologists and health professionals across the country to connect and share ideas

Filed under:Practice SupportTechnology Tagged with:ACR/ARHPrheumatologistSocial MediaTechnology

  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences